1 / 19

Report from the Czech Republic EUROCHIP 2

Report from the Czech Republic EUROCHIP 2. Activities within Eurochip 2. 1) Calculation of 5 year survival by region ; in different regions by most frequent diagnoses 2) Calculation of 5 year survival of women with dg C50, with x without radiotherapy after surgery

rianna
Download Presentation

Report from the Czech Republic EUROCHIP 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report from the Czech Republic EUROCHIP 2 Varenna, 18.10.2007

  2. Activities within Eurochip 2 • 1) Calculation of 5 year survival by region; in different regions by most frequent diagnoses • 2) Calculation of 5 year survival of women with dg C50, withxwithout radiotherapy after surgery • 3) Test of statistical correlation between MN and life style (data from HIS in CR) • 4) Participation in Pilot Studies Varenna, 18.10.2007

  3. Differences between regions • Each region has “good“ and “bad“ survival rates in different diagnoses • We could not find “better” and “worse regions” • Only Prague Region is the best in all diagnoses Varenna, 18.10.2007

  4. Five year survival rate of dg. C18 – C21 females Varenna, 18.10.2007

  5. Five year survival rate of dg. C18-C21-men Varenna, 18.10.2007

  6. Five year survival rate of dg. C50 Varenna, 18.10.2007

  7. Five year survival rate of dg C34 -men Varenna, 18.10.2007

  8. Five year survival rate of all MN men Five year survival rate of all MN females Varenna, 18.10.2007

  9. Calculation of survival rate after surgery (dg C50) Statistically highly significant difference in survival was only found in stage 1, already on level 0.1 %. On the contrary, in higher stages (2 – 4) radiotherapy has no statistically significant influence on the probability of survival. Varenna, 18.10.2007

  10. Varenna, 18.10.2007

  11. Basic Data from HIS CR Varenna, 18.10.2007

  12. Varenna, 18.10.2007

  13. Varenna, 18.10.2007

  14. Varenna, 18.10.2007

  15. Varenna, 18.10.2007

  16. Results from HIS CR Respondents with MN:drink less (5 %) smoke less (1%) have better nutrition habits higher BMI Varenna, 18.10.2007

  17. Problems with Pilot Study • Conversion of Czech form to form of Pilot Study • Entry of 300 cases according to form is not only time consuming, but has hight probability of error. It has to be done manually • Sugestion: to improve data entry – it can be done by computer – but we need structure of record Varenna, 18.10.2007

  18. Problems with Pilot Study Varenna, 18.10.2007

  19. Future • Very difficult situation in our Institute • Number of personnel was cut to one half • Due to serious problem with results from Eurocare study, we are not allowed to present any data from Cancer Registry untilthe data are cleared by Board of Czech Oncological Society I shall be retired at the end of this year and my successor will be Lenka Jurickova Varenna, 18.10.2007

More Related